Pyridostigmine Bromide Oral Suspension (Anhydrous)
Pyridostigmine Bromide is a compounded formulation containing Pyridostigmine Bromide, prepared by Mixlab for veterinary use. Available by prescription.
How to Give Anhydrous Oral Suspension
Oral Suspension (Anhydrous) is a liquid medication that does not contain water in its base. This might be an oil-based or other special base to help stabilize the medicine. It will look like a regular liquid medication, but often needs a good shake because the drug can settle. Here's how to give it:
- Shake well each time to mix the medication (5-10 seconds).
- Measure the dose using the syringe/dropper provided or one recommended by your vet. Insert the top of the oral syringe into the bottle adapter. Turn the bottle upside down and pull the plunger until the medicine reaches the volume required
- Hold your pet steady: a towel or helper can assist with squirmy pets.
- Administer the dose slowly into the side of the mouth. Allow small pauses if needed for swallowing.
- Raise the head slightly to help the medication go down and clean any spills with a little water or tissue.
- Praise your pet and offer a treat or water (unless advised against feeding right after).
- Clean the syringe with water immediately after use. Store the bottle as directed, out of sunlight.
- Consistency is key: Shake each time, measure accurately, and contact your vet if any issues arise.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Pyridostigmine bromide is a cholinesterase inhibitor utilized in veterinary medicine for the management of neuromuscular signaling. It is a prescription medication available for use in dogs and cats, requiring professional guidance and monitoring by a licensed veterinarian. It is frequently considered in the context of myasthenia gravis for patients presented with generalized muscle weakness.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
At a pharmacological level, it is used in the context of managing neuromuscular transmission by inhibiting the enzyme acetylcholinesterase, which offers an approach to increasing the availability of acetylcholine at the nerve-muscle junction. Commonly observed effects include behavioral shifts such as temporary weakness or localized digestive changes like diarrhea and increased salivation. Because it manages muscle tone, your veterinarian will monitor for observational signs of improved mobility. Owners should monitor for significant changes in activity or breathing and contact their veterinarian promptly with concerns.
Yes. Pyridostigmine is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab ensures all legal and professional standards are met before dispensing.
Yes. Mixlab specializes in compounding pyridostigmine into customized strengths and flavored oral formats, such as flavored oral liquids, to support easier administration for your pet.
Veterinarians discuss pyridostigmine because it may help the signals from the nerves reach the muscles. This offers an approach to managing strength and mobility in pets with myasthenia gravis.
Increased salivation and diarrhea are commonly observed effects of cholinergic medications. Your veterinarian will provide guidance on the administration schedule and dose to find the best balance for your pet.
Your veterinarian will recommend periodic check-ups to monitor muscle strength and coordinate the management of any concurrent challenges, such as aspiration pneumonia. This monitoring ensures the approach remains suitable.
